Azitra, Inc. Earnings Per Share (Basic)
Azitra, Inc. (AZTR) reported Earnings Per Share (Basic) of -$0.17 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Azitra, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.17.
- Azitra, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.25.
- Azitra, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.67.
- Azitra, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$1.18.
- Azitra, Inc. earnings per share, basic for fiscal 2025 was -$2.25.
- Azitra, Inc. earnings per share, basic for fiscal 2024 was -$15.70.
- Azitra, Inc. earnings per share, basic for fiscal 2023 was -$54.98.
- Azitra, Inc. earnings per share, basic for fiscal 2022 was -$12.74.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.17 10-Q · filed 2026-08-12 | -$0.42 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | -$0.25 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | -$2.25 10-K · filed 2026-02-27 | |||||||
| 2025-09-30 | -$0.67 10-Q · filed 2025-11-12 | -$3.06 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | -$1.18 10-Q · filed 2026-08-12 | -$0.18 10-Q · filed 2025-08-11 | -$2.69 10-Q · filed 2026-08-12 | -$0.40 10-Q · filed 2025-08-11 | ||||
| 2025-03-31 | -$1.55 10-Q · filed 2026-05-13 | -$0.23 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | -$2.08 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$3.35 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$6.05 derived: net income ÷ weighted average shares · filed 2026-02-27 | -$15.70 10-K · filed 2026-02-27 | -$2.37 10-K · filed 2025-02-24 | |||
| 2024-09-30 | -$1.14 10-Q · filed 2025-11-12 | -$0.17 10-Q · filed 2024-11-12 | -$3.95 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$17.37 10-Q · filed 2025-11-12 | -$2.64 10-Q · filed 2024-11-12 | -$12.35 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||
| 2024-06-30 | -$2.74 10-Q · filed 2025-08-11 | -$6.82 10-Q · filed 2025-08-11 | -$11.79 derived: net income ÷ weighted average shares · filed 2025-08-11 | -$16.31 derived: net income ÷ weighted average shares · filed 2025-08-11 | ||||
| 2024-03-31 | -$4.32 10-Q · filed 2025-05-13 | -$0.15 10-Q · filed 2024-05-09 | -$9.97 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$14.82 derived: net income ÷ weighted average shares · filed 2025-05-13 | -$31.90 derived: net income ÷ weighted average shares · filed 2025-05-13 | |||
| 2023-12-31 | -$6.11 derived: net income ÷ weighted average shares · filed 2025-02-24 | -$10.93 derived: net income ÷ weighted average shares · filed 2025-02-24 | -$32.42 derived: net income ÷ weighted average shares · filed 2025-02-24 | -$54.98 10-K · filed 2025-02-24 | -$1.83 10-K · filed 2024-03-15 | |||
| 2023-09-30 | -$4.82 10-Q · filed 2024-11-12 | -$0.16 10-Q · filed 2023-11-14 | -$29.55 derived: net income ÷ weighted average shares · filed 2024-11-12 | -$58.98 10-Q · filed 2024-11-12 | -$1.97 10-Q · filed 2023-11-14 | -$23.09 derived: net income ÷ weighted average shares · filed 2024-11-12 | ||
| 2023-06-30 | -$70.83 10-Q · filed 2024-08-12 | -$2.36 10-Q · filed 2023-08-14 | -$154.05 10-Q · filed 2024-08-12 | -$5.14 10-Q · filed 2023-08-14 | -$17.84 derived: net income ÷ weighted average shares · filed 2024-08-12 | -$19.88 derived: net income ÷ weighted average shares · filed 2024-08-12 | ||
| 2023-03-31 | -$3.00 10-Q · filed 2024-05-09 | -$7.49 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$10.44 derived: net income ÷ weighted average shares · filed 2024-05-09 | -$12.89 derived: net income ÷ weighted average shares · filed 2024-05-09 | ||||
| 2022-12-31 | -$4.49 derived: net income ÷ weighted average shares · filed 2024-03-15 | -$7.44 derived: net income ÷ weighted average shares · filed 2024-03-15 | -$9.88 derived: net income ÷ weighted average shares · filed 2024-03-15 | -$12.74 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | -$2.95 10-Q · filed 2023-11-14 | -$5.39 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$8.25 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | -$2.45 10-Q · filed 2023-08-14 | -$5.31 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |